A successful challenge in a patient with vancomycin-induced linear IgA dermatosis

Annals of Allergy, Asthma and Immunology

Volumn 93, Issue 1, 2004, Pages 101-103

  Joshi, Sunil ^a   Scott, Glynis ^a   Looney, R John ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOGLOBULIN A; VANCOMYCIN;

ADULT; ANAMNESIS; ARTICLE; BLISTER; BULLOUS SKIN DISEASE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DOSE RESPONSE; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN TISSUE; LABORATORY TEST; LIMB; OSTEOMYELITIS; PRIORITY JOURNAL; PROVOCATION TEST; RASH; RECURRENT DISEASE; SEPSIS; SKIN BIOPSY; SKIN DEFECT; SKIN MANIFESTATION; TRUNK; AUTOIMMUNE DISEASE; CHEMICALLY INDUCED DISORDER; IMMUNOLOGY; MIDDLE AGED;

AUTOIMMUNE DISEASES; FEMALE; HUMANS; IMMUNOGLOBULIN A; MIDDLE AGED; SKIN DISEASES, VESICULOBULLOUS; VANCOMYCIN;

EID: 3843125408     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61454-8     Document Type: Article

References (14)

1. Marinkovich MP, Taylor TB, Keene DR, Burgeson RE, Zone JJ. LAD-1, the linear IgA dermatosis autoantigen is a novel 120 kDa anchoring filament protein synthesized by epidermal cells. J Invest Dermatol. 1996;106:734-738.
2. Kuechle MK, Stegemeir E, Maynard B, Gibson LE, Leiferman KM, Peters MS. Drug-induced linear IgA bullous dermatosis: report of six cases and review of the literature. J Am Acad Dermatol. 1994;30:187-192.
3. Baden LA, Apovian C, Imber MJ, Dover JS. Vancomycin-induced linear IgA bullous dermatosis [letter]. Arch Dermatol. 1988;124:1186-1188.
4. Gabrielson TO, Staerfelt F, Thune PO. Drug-induced bullous dermatosis with linear IgA deposits along the basement membrane. Acta Derm Venereol (Stockh). 1981;61:439-441.
5. Valsecchi R, Serra M, Tornaghi A, Cainelli T. Dermatosi bullosa da farmaio IgA linear. G Ital Dermatol Venereol. 1982;117:221-223.
6. McWhirter JD, Hashimoto K, Fayne S, Ito K. Linear IgA bullous dermatosis related to lithium carbonate. Arch Dermatol. 1987;123:1120-1122.
7. Argenyi ZB, Bergfeld WF, Valenzuela R, McMahon JT, Taylor JS. Adult linear IgA disease associated with an erythema multiforme-like drug reaction. Cleve Clin J Med. 1987;54:445-450.
8. Klein LE, Shmunes E, Carter JB, et al. Linear IgA bullous dermatosis related to captopril treatment. Cutis. 1989;44:393-396.
9. Carpenter S, Berg D, Sidhu-Malik N, Hall RP III, Rico MJ. Vancomycin-associated linear IgA dermatosis: a report of three cases. J Am Acad Dermatol. 1992;26:45-48.
10. Nousari H, Kimyai-Asadi A, Caeiro J, Anhalt G. Clinical, demographic, and immunohistologic features of vancomycin-induced linear IgA bullous disease of the skin: report of 2 cases and review of the literature. Medicine. 1999;78:1-8.
11. Neughebauer B, Negron G, Pelton S, Plunkett RW, Beutner EH, Magnussen R. Bullous skin disease: an unusual allergic reaction to vancomycin. Am J Med Sci. 2002;323:273-278.
12. Palmer R, Ogg G, Allen J, et al. Vancomycin-induced linear IgA disease with autoantibodies to BP 180 and LAD 285. Br J Dermatol. 2001;145:816-820.
13. Richards SS, Hall S, Yokel B, Whitmore E. A bullous eruption in an elderly woman: vancomycin-associated linear IgA dermatosis. Arch Dermatol. 1995;131:1447-1448, 1450-1451.
14. Kashihara M, Danno K, Miyachi T. Bullous pemphigoid-like lesions induced by phenacetin. Arch Dermatol. 1984;120:1196-1199.